Top

Zantac Recall Cancer Lawsuit

Zantac (ranitidine) is taken for conditions including heartburn, acid indigestion, sour stomach, gastroesophageal reflux disease (GERD), ulcers, and erosive esophagitis, among others. The FDA has recently announced multiple recalls of Zantac and its generic formulation ranitidine due to contamination with the probable human carcinogen N-Nitrosodimethylamine (NDMA).

If you or a loved one has been diagnosed with cancer after taking Zantac or ranitidine, contact one of our Minnesota Cancer Lawyers today. Our team has over 30 years of complex litigation experience and will deliver the Gold standard advocacy you deserve.

Call 800-903-1643 >

Case Quick Facts

The Problem

On September 9, 2019, an independent pharmacy, Valisure, filed a Citizens’ Petition with the FDA, asking the FDA to require a complete recall of all Zantac and ranitidine products, among other things.

In the Citizens’ Petition, Valisure explains that the ranitidine molecule is very unstable.  As a result of the way the human body breaks down the medication, NDMA is formed inside the human body.

What happens when you are exposed to NDMA?

NDMA is classified as a probable human carcinogen and as a known animal carcinogen.  Therefore, exposure over prolonged periods of time or in high and concentrated doses to NDMA can cause a variety of types of cancer.

The Injuries

NDMA has been linked to the following types of cancers in medical studies:

  • Stomach cancer
  • Bladder Cancer
  • Intestinal cancer (in both the large and small intestine)
  • Colon cancer/ colorectal cancer
  • Esophageal cancer
  • Liver cancer
  • Prostate cancer
  • Pancreatic cancer
  • Leukemia
  • Non-Hodgkin’s Lymphoma
  • Kidney Cancer
  • Multiple Myeloma
The Defendants

Zantac was first approved in 1983 and was manufactured by Glaxo Holdings, Ltd. (now GlaxoSmithKline).  In 2004, Pfizer received FDA approval to sell over-the-counter Zantac, and rights were subsequently transferred from Pfizer to Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, and to Sanofi.  Sanofi sold branded, over-the-counter Zantac until it recalled the product in October 2019.  Other types of branded Zantac (the injectable solution) have been made by Teligent.

Generic versions of Zantac (ranitidine) have been manufactured and sold within the United States for years by a number of different manufacturers, including Novitium Pharma, Mylan, Sandoz, Ani Pharms, Inc., Apotex, Bedford, West-ward Pharms Int., Watson Labs, Ranbaxy, Contract Pharmacal, Sun Pharms, Industries Ltd., Heritage Pharma, Par Pharm, Wockhardt, Ltd., Dr. Reddy’s Labs, Ltd., Teva, Actavis Mid Atlantic, Perrigo, Pharm Assoc., Taro, Amneal Pharms NY, Glenmark Pharms, Inc., Breckenridge, Lannett Co., Inc., Anda Repository, Torrent, Aurobindo Pharma, Ltd., Hi Tech Pharma, Nostrum Labs, Inc., Zydus Pharms USA, Inc., Strides Pharma, Acic Pharms, Ajanta Pharma, ltd., Unique Farm Labs, Granules India Ltd., VKT Pharma PVT Ltd., and Appco Pharma, LLC.

GoldenbergLaw Can Help

GoldenbergLaw is currently investigating cases where an individual has taken Zantac or ranitidine and developed cancer. We have been litigating defective pharmaceutical cases for over thirty years and have the knowledge, experience and compassion you deserve.

Contact us today for a free consultation.

Do I Qualify?
Handshake icon

A Personal Message From Senior Partner Stuart Goldenberg

Senior Partner Stuart GoldenbergWe often hear the phrase that “cancer does not discriminate.” However, we are now learning that defects in everyday products like Zantac could be contributing to the astronomical increase in cancer diagnoses in America. This news is devastating, and completely unacceptable. GoldenbergLaw has worked for many years to hold negligent manufacturers accountable for dangerous products. We have helped thousands of people obtain justice, and we are here for you now. We will help you with care and concern to understand your rights and choices. Please give us a chance to help you.

 

Call 800-903-1643

Zantac FDA Recall Timeline

September 13, 2019: The FDA issues a statement alerting the public that some ranitidine medications were found to contain NDMA.

September 24, 2019: The FDA announces that Sandoz, Inc. is recalling 14 lots of prescrtiption ranitidine capsules due to the confirmed detection of NDMA.

September 25, 2019: The FDA announces that Apotex Corp. is recalling all lots of its 75 mg and 150 mg over-the-counter ranitidine tablets on a “precautionary basis” due to findings of NDMA in ranitidine medications. This recall includes many lots sold under store names at Rite Aid, Walmart, and Walgreens.

October 2, 2019: The FDA asks manufacturers to use a Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) testing method for detecting NDMA in their ranitidine medications. The agency announces it will begin testing ranitidine oral medications along with other H2 blockers and proton-pump inhibitors for NDMA impurities.

October 23, 2019: The FDA announces that Dr. Reddy’s Laboratories Ltd. is recalling all lots of its prescription and over-the-counter ranitidine medications due to confirmed NDMA contamination. This recall includes many lots sold under store names at Kroger, Walgreens, Walmart, CVS, and Target.

October 23, 2019The FDA announces that Sanofi is recalling all lots of its Zantac OTC products sold in the United States and Canada due to “inconsistencies” in test results conducted after NDMA contaminations were found by other manufacturers. This recall includes Zantac 150, Zantac 150 Cool Mint, and Zantac 75.

October 23, 2019: The FDA announces that Perrigo Company plc is issuing a worldwide recall of all lots of its ranitidine medications due to the “possible presence” of NDMA impurities.

October 25, 2019: The FDA announces that Novitium Pharma is recalling all lots of its Ranitidine Hydrochloride Capsules in the United States due to potential unsafe levels of NDMA. This recall includes prescription strength Ranitidine Hydrochloride 150 mg and 300 mg Capsules.

October 25, 2019: The FDA announces that Lannett Company Inc. is recalling all lots of its Ranitidine Syrup due to confirmed unsafe levels of NDMA. This recall includes all prescription strength Ranitidine Hydrochloride Oral Solution.

 

 

 

Zantac Lawsuit FAQs

Do I Have A Zantac Case?

If you have taken Zantac or ranitidine and been diagnosed with cancer, you may have a case against the manufacturers. Contact GoldenbergLaw today for a free case evaluation.

Why Is Zantac Being Recalled?

Zantac and ranitidine are being recalled due to contamination with the probable human carcinogen NDMA. According to Valisure’s Citizen’s Petition, all types of Zantac and ranitidine are affected by the NDMA contamination.  The problem is with the molecular structure of the drug, which is consistent across all types of both branded Zantac and generic ranitidine.

Is All Zantac Recalled?

While some countries like Canada required a complete ban on the sale and distribution of Zantac and ranitidine, the FDA in the United States has not required one to date.  However, a number of individual manufacturers have recalled their Zantac and ranitidine products.

Should I Continue Taking Zantac?

The FDA recommends that patients who wish to stop taking prescription versions of Zantac and ranitidine should speak with their physicians before making any changes.  The FDA further noted that consumers taking over-the-counter versions of Zantac or ranitidine can consider other other-the-counter alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole).  Testing conducted by FDA to date have not shown any NDMA in these mediations.

What Is The FDA Doing About The Zantac Recall?

On September 13, 2019, the FDA released a statement, indicating that “some ranitidine medicines” contain NDMA “at low levels.” FDA further indicated the agency would be examining levels and the possible risk to patients.

Since that time, Sandoz, Apotex Corporation (which also manufactured the Rite Aid, Walmart, and Walgreens brand tablets), Perrigo Company Plc, Novitium, Dr. Reddy’s (which also manufactured Sam’s Club, Kroger, Walgreens, Walmart, CVS, CDMA, HCA, Target, Thirty Madison, and GeriCare ranitidine products), Sanofi, and Lannett Company, Inc. have recalled some or all of their Zantac products.

Can I Still Take Zantac While I Am Pregnant?

For years, Zantac has been classified as a Category B medication, meaning that it is safe for use during pregnancy.  Specifically, a medication placed into Category B means that animal reproduction studies have failed to demonstrate a risk to the fetus, and there are no well-controlled studies in pregnant women.  While this may sound a little frightening, there are very few medications in Category A, simply because it is exceptionally difficult to run studies on pregnant women due to ethical issues.

However, some studies have shown that NDMA can cross the placental barrier.  For this reason, we recommend talking with your doctor about what course of action might be safest for you and your baby.

Why Are We Hearing So Much About NDMA In Medications?

NDMA and other related nitrosamines (such as NDEA and NMBA) were also discovered in other medications, including valsartan and losartan somewhat recently.  While the reason for the contamination in those drugs relates to the manufacturing process, as opposed to the molecular makeup of the drug, the risks of NDMA exposure can result in many of the same types of cancers and other complications.

What Compensation Am I Entitled To In A Zantac Lawsuit?

If you have been diagnosed with cancer after using Zantac or ranitidine, you may be entitled to compensation for your injuries. Contact GoldenbergLaw for a free consultation and to learn more about the Zantac litigation.

Free Consultations

 

If you or a loved one developed cancer after taking Zantac or ranitidine, contact GoldenbergLaw today for a complementary consultation.  We have extensive experience in litigating contaminated drug cases and believe strongly in promoting safety through accountability.

Contact Us Call 800-903-1643

Why Choose GoldenbergLaw?

When it comes to Zanatc lawsuits, our Zantac Cancer litigation team is ready to help you discuss your options. We’ve have over thirty years of experience representing cancer victims, let us deliver the Gold standard advocacy you deserve.

Thousands of Successful Settlements

Comprehensive Knowledge of Complex Issues

Focused on Client-Centered Solutions

Meet Your Zantac Team

Attorney Referral

Have a potential client we could help?

Referral Form

Free Consultation

Call us. You’ll sleep better.

Schedule Now